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Figure 1. Diagram Illustrating the Formation,
Screening, and Analysis of a Small Molecule
Library Displayed on Phage
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quence and high-density gene expression arrays came,Ontology Recapitulates Physiology
followed by high-throughput bioassays, SNPs, pro-
teome biochips, and, more recently, genome-wide gene
knockdown screens in cells, the collective interpretation
of which, in the absence of “A Beautiful Mind,” is compu-
High-content information experiments in the post-
tationally challenging [1–6]. Needless to say, the influx
genomic era hold the promise of deciphering age-old
of large-scale data sets has shifted the biomedical re-
questions in biology and new ones in the biomedical search focus toward challenges in computational sci-
arena. In response, researchers are devising computa- ence [7]. Extracting knowledge contained in the patterns
tionally intensive and novel strategies to extract an- of these experiments into a structured format useful
swers from multidimensional data sets. to biologists and medical researchers may highlight an
underlying “method to the madness” and could prove
The post-genomic era has brought with it a vast collec- critical to an understanding of how cells work.
tion of data from disparate sources, raising new ques- Attempts to systematically identify novel gene and/
tions about how to interpret the information and derive or drug function from genome-scale data have thus far
relied on acts of heroism both at the bench and in frontsomething meaningful. First, the human genome se-
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of the computer. For example, Hughes et al. collected ture network for 14,000 human genes extracted from
titles and abstracts of 10 million Medline records [12].and assembled a reference database of gene expression
profiles from over 300 gene mutations and chemical PubGene is based on the assumption that if two genes
are comentioned in a report, there is an underlying bio-treatments in yeast and, using a pattern-matching algo-
rithm, were able to assign function to eight novel open logical relationship. Remarkably, despite the obvious
caveats (for example, “Gene X does NOT bind to Genereading frames and identify the biochemical target of
the topical anesthetic small molecule dyclonine [8]. The Y” would still register as a positive association), a re-
markable enrichment for associated genes was foundkey insight here was to generate a reference database
with enough samples to extract statistical meaning from when compared to the Database of Interacting Proteins
(DIP). The main application of PubGene has been to linkthe subtle differences between expression profiles. The
other insight was to run the experiment in yeast, a geneti- gene expression profiles to biomedical literature to cre-
ate “literature gene networks” which, by linking to thecally tractable organism for which a knockout of each
of its 6000 genes exists. Presumably, to perform the MeSH index terms (medical subject headings) such as
blood coagulation, inflammation, and chemotaxis, allowsame feat in human cells would require an order of
magnitude larger data set and be restricted to a single assignment of associated gene networks to biological
processes.cell type.
An equally Herculean effort was undertaken by the Analogous efforts in the small molecule realm are be-
ing undertaken. In this issue of Chemistry & Biology,National Cancer Institute (NCI) in order to bin, by mecha-
nism, cytotoxic small molecules as a function of tumor Root et al. describe a set of chemical and computational
tools designed to identify previously unknown associa-cell selectivity. Over time, the results have led to an
extensive screening database in which measures of tions between mechanism and cellular phenotype [13].
In essence, the authors establish a “mechanism of ac-growth inhibition (log(GI50)) of over 100,000 compounds
tested against various subsets of 60–100 tumor cell lines tion” ontology for small molecule compounds: a formal
specification to represent compounds and the func-were cataloged. In order to extract meaning from the
data set, a relatively new computational tool based on tional landscape they populate. First, by assembling a
collection of well-defined, biologically active com-self-organizing maps (SOMs) was implemented to derive
testable hypotheses [9]. The mapping strategy allowed pounds (termed ACL, annotated compound library), then
assigning to each compound multiple mechanistic,compound selectivity patterns to be segregated into
highly similar response sets. Then, by analogy to both functional descriptors, reinforcing the relevance of these
classifications a` la Jenssen et al., and calculating thethe patterns and map location of very well characterized,
known compounds, novel compounds could be as- coincidence between compound and descriptor in over
11,000,000 Medline records (termed global mechanismsigned a putative mechanism (i.e., purine biosynthesis,
antifolates, apoptosis) and sometimes a precise target extraction), a substantial reference database for known
drugs was realized. The value of this is illustrated experi-family (i.e., topisomerase, cyclin-dependent kinases
[CDKs]) [10]. Once again, the key insight that allowed mentally when the authors screen the compound library
for antiproliferative activity in A549 human lung carci-such fine-tuned classification of compound mechanism
was the use of a substantial reference database. Both of noma cells and discover a series of active hits. Predict-
ably, many of the active compounds are associated withthese studies attest to the idea that a novel, undescribed
gene or drug’s mechanism of action can be inferred by tumor or cell death-related terms in Medline; however,
a surprising but statistically significant enrichment foranalogy to a compendium of established data. Because
of the significant time and capital expenditure required the descriptor “ionophore,” a term previously unassoci-
ated with cell death was uncovered and later verifiedto create such reference databases, researchers have
begun looking for alternatives. empirically. By this approach, a previously untested hy-
pothesis, that an ionophore-dependent mechanismThe clear advantage of employing well-described in-
formation has recently inspired methods to extract infor- might selectively halt A549 tumor cell proliferation, could
be made. Thus, the authors have demonstrated the util-mation from undiscovered public knowledge repositor-
ies and bibliographic databases, (a.k.a. “free” bases). ity of their ontology, when coupled with a selection
scheme, for finding novel associations and identifyingSources such as the Medline citation database (http://
www.ncbi.nlm.nih.gov/PubMed) of the National Library unanticipated mechanisms contributing to a cellular
phenotype. In doing so, the authors have laid the foun-of Medicine (NLM) and other biomedical indices repre-
sent an excellent source for extracting high-density dation for novel, nondeterministic small molecule mech-
anism prediction. Taken to its extreme, the expansion of“data” on gene and drug function. Unfortunately, be-
cause of wide variations in terminology inherent in ar- the annotated library and the incorporation of additional
descriptors to the ontology will allow more demandingchives like Medline compiled over many years from an
equally wide range of sources, establishing controlled determinations, such as the precise molecular target
shared between compounds.vocabularies is essential. Stanford University investiga-
tors, and recently others, formed the Gene Ontology One might ask oneself how much useful information
these approaches might afford, which is exactly what(GO) Consortium to undertake this onerous “normaliza-
tion” process and created a critical guide to accurately informaticians developing analogous methods to ex-
tract biomolecular interaction networks, gene regulatoryassociate genes with processes, cellular components,
and molecular functions [11]. Shortly thereafter, an effort networks, and metabolic pathways from the literature
(MeKE, KEGG) are going to find out [14, 15]. In fact, theto mine Medline for gene function was exacted by Jens-
sen et al. in the assembly of PubGene, a full-scale litera- company Ingenuity was launched to develop knowl-
Chemistry & Biology
786
4. Jurinke, C., van den Boom, D., Cantor, C.R., and Koster, H.edge-based systems using natural language-processing
(2002). Adv. Biochem. Eng. Biotechnol. 77, 57–74.techniques and full-text literature mining tools for more
5. Zhu, H., Bilgin, M., Bangham, R., Hall, D., Casamayor, A., Ber-comprehensive pathway analysis (Ingenuity, CA). Clearly,
tone, P., Lan, N., Jansen, R., Bidlingmaier, S., Houfek, T., et al.
advances in text mining of factual and literature data- (2001). Science 293, 2101–2105.
bases are extending the knowledge base further, dem- 6. Ziauddin, J., and Sabatini, D.M. (2001). Nature 411, 107–110.
7. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S.,onstrating how text-based information repositories can
Dmitrovsky, E., Lander, E.S., and Golub, T.R. (1999). Proc. Natl.be used as multidimensional data troves for deciphering
Acad. Sci. USA 96, 2907–2912.genomic scale experiments.
8. Hughes, T.R., Marton, M.J., Jones, A.R., Roberts, C.J., Stough-
ton, R., Armour, C.D., Bennett, H.A., Coffey, E., Dai, H., He, Y.D.,
et al. (2000). Cell 102, 109–126.Jeremy S. Caldwell
9. Sherlock, G. (2000). Curr. Opin. Immunol. 2, 201–205.Department of Drug Discovery
10. Rabow, A.A., Shoemaker, R.H., Sausville, E.A., and Covell, D.G.
Genomics Institute of the Novartis Research Foundation (2002). J. Med. Chem. 45, 818–840.
San Diego, California 92121 11. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H.,
Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T.,
Selected Reading et al. (2000). Nat. Genet. 25, 25–29.
12. Jenssen, T.K., Laegreid, A., Komorowski, J., and Hovig, E.
1. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., (2001). Nat. Genet. 28, 21–28.
Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., 13. Root, D.E., Flaherty, S.P., Kelley, B.P., and Stockwell, B.R.
et al. (2001). Science 291, 1304–1351. (2003). Chem. Biol. 10, this issue, 881–892.
2. Lipshutz, R.J., Fodor, S.P., Gingeras, T.R., and Lockhardt, D.J. 14. Chiang, J.H., and Yu, H.C. (2003). Bioinformatics 19, 1417–1422.
(1999). Nat. Genet. 21, 20–24. 15. Ogata, H., Goto, S., Fujibuchi, W., and Kanehisa, M. (1998).
Biosystems 47, 119–128.3. Sundberg, S.A. (2000). Curr. Opin. Biotechnol. 11, 47–53.
